01—Abstract
Summary
Summary of the 8-K filed November 3, 2025. Cited figures are marked; the original filing is the authoritative source.
On November 2, 2025, Kimberly-Clark Corporation (K-C) entered into an Agreement and Plan of Merger with Kenvue Inc. under which Kenvue will become a wholly owned subsidiary of K-C through a two-step merger.
Kenvue common stockholders will receive 0.14625 shares of K-C common stock plus $3.50a in cash for each Kenvue share, which the joint press release values at a total of $21.01 per share based on K-C's October 31, 2025 closing price. The press release states an enterprise value of approximately $48.7 billion, a headline multiple of approximately 14.3x Kenvue's LTM adjusted EBITDA, and an effective multiple of 8.8x including expected run-rate synergies of $2.1 billion, net of reinvestment. Upon closing, K-C shareholders are expected to own approximately 54% and Kenvue shareholders approximately 46% of the combined company on a fully diluted basis.
The transaction is subject to approval by both companies' stockholders, U.S. HSR and other antitrust and regulatory clearances, and effectiveness of a Form S-4. The merger agreement includes a $1,136,000,000b termination fee payable in specified circumstances and an Outside Date of November 2, 2026, extendable to May 3, 2027 in certain cases. The companies expect the transaction to close in the second half of 2026.
K-C has secured a $7.7 billionc bridge facility commitment from JPMorgan Chase Bank, N.A. to fund the cash consideration and related fees and expenses, to be backstopped by debt offerings, loans, or specified dispositions, including the previously announced sale of a 51% interest in its International Family Care and Professional business. The press release projects the combined company will have approximately $32 billion in 2025 annual net revenues and approximately $7 billion of adjusted EBITDA, with approximately $1.9 billion in cost synergies and $500 million in incremental profit from revenue synergies, partially offset by about $300 million of reinvestment. Kimberly-Clark expects $2.5 billion of cash costs to achieve these synergies, and the press release states the transaction is expected to be accretive to adjusted EPS by year two.
02—Key points
Key Highlights
- Merger consideration per Kenvue share: 0.14625 K-C common shares plus $3.50 in cash, totaling $21.01 per share based on K-C's October 31, 2025 closing price.
- Enterprise value of approximately $48.7 billion, with a headline multiple of 14.3x Kenvue LTM adjusted EBITDA and 8.8x including $2.1 billion of expected run-rate synergies, net of reinvestment.
- Pro forma ownership of approximately 54% for current K-C shareholders and approximately 46% for current Kenvue shareholders on a fully diluted basis.
- Bridge facility commitment of $7.7 billion from JPMorgan Chase Bank, N.A. to fund the $3.50 cash consideration and related fees and expenses.
- Expected synergies of approximately $1.9 billion in cost synergies and $500 million in incremental profit from revenue synergies, offset by about $300 million of reinvestment, with $2.5 billion of cash costs to achieve.
- Closing subject to Kenvue and K-C stockholder approvals, HSR and other regulatory clearances, and an effective Form S-4; target closing in the second half of 2026.
- Termination fee of $1,136,000,000 payable in specified circumstances, and an Outside Date of November 2, 2026, subject to extension to May 3, 2027 in certain cases.
03—Questions
Frequently Asked Questions
What will Kenvue shareholders receive in the transaction?
Each Kenvue common share will be converted into 0.14625 shares of K-C common stock plus $3.50 in cash. Based on K-C's October 31, 2025 closing price, the press release values this at $21.01 per Kenvue share. Cash paid in lieu of fractional shares is also provided for.
How will ownership of the combined company be split?
Upon closing, current K-C shareholders are expected to own approximately 54% and current Kenvue shareholders approximately 46% of the combined company on a fully diluted basis.
What conditions must be met for the deal to close?
Closing requires approval by Kenvue stockholders of the merger agreement and by K-C stockholders of the share issuance, expiration or termination of the HSR waiting period and certain foreign clearances, no governmental restraints, effectiveness of the Form S-4, Nasdaq listing approval for the new shares, and accuracy of representations and performance of obligations in all material respects. The companies expect closing in the second half of 2026.
How will Kimberly-Clark finance the cash portion of the deal?
K-C has a $7.7 billion bridge facility commitment from JPMorgan Chase Bank, N.A., available if debt offerings, loan facilities, or specified dispositions do not provide sufficient proceeds. The press release says K-C intends to fund the cash component through balance sheet cash, new debt issuance, and proceeds from the sale of a 51% interest in its International Family Care and Professional business.
What are the main termination risks for the deal?
Either party may terminate if the merger is not completed by the November 2, 2026 Outside Date (extendable to May 3, 2027 in certain cases), if required stockholder approvals are not obtained, if a final nonappealable legal restraint exists, or upon material breach or a change in board recommendation. A $1,136,000,000 termination fee applies in specified circumstances, including a change in recommendation or failure to obtain approval while a third-party alternative proposal is pending and a related transaction follows within 12 months.
04—Continue